Cite Filings / RARE / 0002012383-26-003116
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Ultragenyx Pharmaceutical Inc. · Filed 2026-07-30 · Acc 0002012383-26-003116

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-04 4 EVP and Chief Legal Officer sold 1,900 shares at $24.92 ($47,348)
  • 2026-08-04 4 Chief Financial Officer sold 4,696 shares at $24.92 ($117,024)
  • 2026-08-03 144 Sale of Securities
  • 2026-07-31 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-07-31 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-07-30 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…